Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
Asian Journal of Neurosurgery|April 9, 2016
Spinal arteriovenous malformations: Is surgery indicated?Bikramjit Singh, Sanjay Behari, Awadhesh K Jaiswal, et al.
Neurology India|June 9, 2015
Risk stratification of vertebral artery vulnerability during surgery for congenital atlanto-axial dislocation with or without an occipitalized atlasJayesh Sardhara, Sanjay Behari, B Madan Mohan, et al.
Blood|May 23, 1998
Detection of lymphoma in bone marrow by whole-body positron emission tomographyR Carr, S F Barrington, B Madan, et al.
Interventional Neuroradiology : Journal of Peritherapeutic Neuroradiology, Surgical Procedures and Related Neurosciences|July 1, 2014
Endovascular treatment in spinal perimedullary arteriovenous fistulaRajendra V Phadke, Avik Bhattacharyya, Akash Handique, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|February 4, 2009
Consensus protocol for the use of recombinant activated factor VII [eptacog alfa (activated); NovoSeven] in elective orthopaedic surgery in haemophilic patients with inhibitorsP L F Giangrande, J T Wilde, B Madan, et al.
Bone Marrow Transplantation|April 25, 2006
A randomized phase III comparative trial of immediate consolidation with high-dose chemotherapy and autologous peripheral blood progenitor cell support compared to observation with delayed consolidation in women with metastatic breast cancer and only bone metastases following intensive induction chemotherapyJ J Vredenburgh, B Madan, D Coniglio, et al.
Blood Cancer Journal|July 26, 2012
Pacritinib (SB1518), a JAK2/FLT3 inhibitor for the treatment of acute myeloid leukemiaS Hart, K C Goh, V Novotny-Diermayr, et al.
Oncogene|August 11, 2015
Wnt addiction of genetically defined cancers reversed by PORCN inhibitionB Madan, Z Ke, N Harmston, et al.
Leukemia|June 22, 2011
SB1518, a novel macrocyclic pyrimidine-based JAK2 inhibitor for the treatment of myeloid and lymphoid malignanciesS Hart, K C Goh, V Novotny-Diermayr, et al.
Pageof 2